Aptus Capital Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Aptus Capital Advisors's BSX Position: Q3 2026 in Review
Aptus Capital Advisors increased its Boston Scientific (BSX) stake by 1,171% in Q3 2026, buying an estimated $3.03M and bringing the position to 71,074 shares worth $3.1M. The position accounts for 0.02% of the portfolio, ranked #461.
Aptus Capital Advisors first reported a position in BSX in Q1 2019 and has held it in 17 quarters since. The position peaked at $7.44M in Q4 2025. 1,515 funds tracked by Wall St. Rank hold BSX as of Q3 2026.
- Aptus Capital Advisors held 71,074 shares of Boston Scientific worth $3.1M as of Q3 2026.
- Aptus Capital Advisors bought 65,480 Boston Scientific shares in Q3 2026, an estimated $3.03M.
- Boston Scientific made up 0.02% of Aptus Capital Advisors's portfolio in Q3 2026, its #461 holding.
- Aptus Capital Advisors first reported a position in Boston Scientific in Q1 2019 and has held it in 17 quarters since.
- Aptus Capital Advisors's Boston Scientific position peaked at $7.44M in Q4 2025.
- 1,515 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.
Based on Aptus Capital Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.